Pfizer Inc recalls Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-274
Recalled June 26, 2013 · FDA recall D-607-2013 · Pfizer
Hazard
Failed Dissolution Specification · FDA Class III
Units
5,410 botlles
Sold at
Nationwide and Puerto Rico
Description
Failed Dissolution Specification
Product
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Manufacturer(s)
Pfizer Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →